An interventional study of Maitland Grade III Mobilization and Mulligan Mobilization with Movement (MWM) in Joint Instability and Ankle Injuries, sponsored by University of Management and Technology Lahore. Active, not recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this clinical trial is to learn which of two hands-on ankle treatments works better for amateur footballers aged 18 to 35 with unstable ankles, meaning ankles that keep "giving way" after an old sprain. The study will find out which treatment better improves how far the ankle bends upward, balance while standing and reaching on one leg, and hopping on the injured leg compared with the healthy leg. Researchers will compare Maitland mobilization, where the therapist gently and rhythmically moves the ankle joint while the participant lies still, with Mulligan mobilization, where the therapist holds the ankle bones in a guided position while the participant bends the ankle. Participants will receive one of the two treatments, followed by ankle strengthening exercises, 3 times a week for 8 weeks. They will complete simple tests of ankle movement, balance and hopping at the start, at week 4 and at week 8.
117 studies on the registry are indexed under Joint Instability; 22 are open to participants now.
This study's enrollment of 44 is close to the median of 45 across 59 interventional studies indexed under Joint Instability.
Browse Joint Instability studies →University of Management and Technology Lahore is the lead sponsor of 42 studies on the registry; 20 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Maitland Grade III talocrural mobilization followed by a peroneal strengthening programme, 3 sessions per week for 8 weeks.
Other: Maitland Grade III Mobilization
Mulligan mobilization with movement followed by the same peroneal strengthening programme, 3 sessions per week for 8 weeks.
Other: Mulligan Mobilization with Movement (MWM)
Maitland Grade III talocrural joint mobilization applied by the treating physical therapist with the participant in supine and the ankle over the edge of the treatment couch. Large-amplitude oscillatory glides are performed up to the limit of available range to restore talar accessory glide and improve dorsiflexion. Dosage: 3 sets of 60 seconds per session with 30 to 60 seconds rest between sets.
A sustained fibular / antero-posterior accessory glide is applied by the therapist while the participant actively performs pain-free dorsiflexion (e.g., weight-bearing lunge). Dosage: 10 repetitions per set, 3 sets, with adequate rest between sets.
Ankle Dorsiflexion Range of Motion: Weight-Bearing Lunge Test (WBLT)
Measures ankle dorsiflexion ROM under functional, weight-bearing conditions. The participant lunges forward so the knee touches a wall while the heel stays on the ground; the maximum distance between the great toe and the wall (cm), or the tibial inclination angle measured with an inclinometer, is recorded. Greater values indicate more dorsiflexion.
Time frame: Baseline, Week 4 (interim) and Week 8 (post-intervention)
Star Excursion Balance Test (SEBT)
A validated clinical measure of dynamic postural control and neuromuscular control. The participant stands barefoot on the test limb at the centre of a grid of eight lines at 45 degree increments and reaches as far as possible with the opposite limb in eight directions (anterior, anteromedial, medial, posteromedial, posterior, posterolateral, lateral, anterolateral). Three successful trials are performed per direction. Reach distances are normalized to limb length and expressed as a percentage of limb length; greater values indicate better dynamic balance.
Time frame: Baseline, Week 4 (interim) and Week 8 (post-intervention)
Single-Leg Hop Tests, Limb Symmetry Index (LSI)
A battery of single-leg hop tests (single hop for distance, triple hop for distance, crossover hop for distance and timed 6-metre hop). Performance of the involved limb is expressed as a Limb Symmetry Index (%) relative to the uninvolved limb; higher LSI indicates more symmetrical hop performance.
Time frame: Baseline, Week 4 (interim) and Week 8 (post-intervention)
Plan to share: Yes — De-identified individual participant data underlying the published results will be shared.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: 6 months after the publication of the manuscript.
Access criteria: The data can be requested from the corresponding author.
Started Nov 2026 (actual). Primary completion is estimated for Jan 2027, 2 months after the start.
Of 37 non-industry interventional studies with no phase under Joint Instability, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 37. This study's planned 2 months is below that.
Counting every sponsor, half of 42 studies reached it within 15 months; a quarter within 7 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Management and Technology Lahore